1 Min Read
Oct 26 (Reuters) - Bioinvent
* Q3 net sales amounted to SEK 7.1 (0.8) million.
* Q3 earnings after tax: SEK -21 (-29) million. Source text for Eikon: Further company coverage: (Stockholm Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.